The global market for Ocular Drug Delivery was valued at US$ 26590 million in the year 2024 and is projected to reach a revised size of US$ 36740 million by 2031, growing at a CAGR of 4.8% during the forecast period.

Ocular Drug Delivery Market

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Ocular Drug Delivery, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Ocular Drug Delivery.

The Ocular Drug Delivery market size, estimations, and forecasts are provided in terms of sales volume (K Doses) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Ocular Drug Delivery market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Ocular Drug Delivery manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Ocular Drug Delivery Market Report

Report Metric	Details
Report Name	Ocular Drug Delivery Market
Accounted market size in year	US$ 26590 million
Forecasted market size in 2031	US$ 36740 million
CAGR	4.8%
Base Year	year
Forecasted years	2025 - 2031
Segment by Type	Ocular Insert Iontophoresis Intraocular Implants In Situ Gel & Punctal Plugs Others
Segment by Application	Hospitals Ambulatory Surgical Centers Ophthalmic Clinics Homecare Settings
Consumption by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Asia-Pacific (China, Japan, South Korea, Taiwan) Southeast Asia (India) Latin America (Mexico, Brazil)
By Company	OCULAR THERAPEUTIX, INC, Alimera Sciences, Allergan, Plc, EyeGate Pharma, Valeant Pharmaceuticals International, Inc, Envisia Therapeutics, Clearside Biomedical, Graybug Vision Inc, Taiwan Liposome Company, Santen Pharmaceutical
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Ocular Drug Delivery manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Ocular Drug Delivery in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

FAQ for this report

How fast is Ocular Drug Delivery Market growing?

Ans: The Ocular Drug Delivery Market witnessing a CAGR of 4.8% during the forecast period 2025-2031.

What is the Ocular Drug Delivery Market size in 2031?

Ans: The Ocular Drug Delivery Market size in 2031 will be US$ 36740 million.

Who are the main players in the Ocular Drug Delivery Market report?

Ans: The main players in the Ocular Drug Delivery Market are OCULAR THERAPEUTIX, INC, Alimera Sciences, Allergan, Plc, EyeGate Pharma, Valeant Pharmaceuticals International, Inc, Envisia Therapeutics, Clearside Biomedical, Graybug Vision Inc, Taiwan Liposome Company, Santen Pharmaceutical

What are the Application segmentation covered in the Ocular Drug Delivery Market report?

Ans: The Applications covered in the Ocular Drug Delivery Market report are Hospitals, Ambulatory Surgical Centers, Ophthalmic Clinics, Homecare Settings

What are the Type segmentation covered in the Ocular Drug Delivery Market report?

Ans: The Types covered in the Ocular Drug Delivery Market report are Ocular Insert, Iontophoresis, Intraocular Implants, In Situ Gel & Punctal Plugs, Others

1 Ocular Drug Delivery Market Overview

1.1 Product Definition

1.2 Ocular Drug Delivery by Type

1.2.1 Global Ocular Drug Delivery Market Value Comparison by Type (2024 VS 2031)

1.2.2 Ocular Insert

1.2.3 Iontophoresis

1.2.4 Intraocular Implants

1.2.5 In Situ Gel & Punctal Plugs

1.2.6 Others

1.3 Ocular Drug Delivery by Application

1.3.1 Global Ocular Drug Delivery Market Value by Application (2024 VS 2031)

1.3.2 Hospitals

1.3.3 Ambulatory Surgical Centers

1.3.4 Ophthalmic Clinics

1.3.5 Homecare Settings

1.4 Global Ocular Drug Delivery Market Size Estimates and Forecasts

1.4.1 Global Ocular Drug Delivery Revenue 2020-2031

1.4.2 Global Ocular Drug Delivery Sales 2020-2031

1.4.3 Global Ocular Drug Delivery Market Average Price (2020-2031)

1.5 Assumptions and Limitations

2 Ocular Drug Delivery Market Competition by Manufacturers

2.1 Global Ocular Drug Delivery Sales Market Share by Manufacturers (2020-2025)

2.2 Global Ocular Drug Delivery Revenue Market Share by Manufacturers (2020-2025)

2.3 Global Ocular Drug Delivery Average Price by Manufacturers (2020-2025)

2.4 Global Key Players of Ocular Drug Delivery, Industry Ranking, 2022 VS 2023 VS 2024

2.5 Global Key Manufacturers of Ocular Drug Delivery, Manufacturing Sites & Headquarters

2.6 Global Key Manufacturers of Ocular Drug Delivery, Product Type & Application

2.7 Global Key Manufacturers of Ocular Drug Delivery, Date of Enter into This Industry

2.8 Global Ocular Drug Delivery Market Competitive Situation and Trends

2.8.1 Global Ocular Drug Delivery Market Concentration Rate

2.8.2 The Global 5 and 10 Largest Ocular Drug Delivery Players Market Share by Revenue

2.8.3 Global Ocular Drug Delivery Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

2.9 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Global Ocular Drug Delivery Market Scenario by Region

3.1 Global Ocular Drug Delivery Market Size by Region: 2020 Versus 2024 Versus 2031

3.2 Global Ocular Drug Delivery Sales by Region: 2020-2031

3.2.1 Global Ocular Drug Delivery Sales by Region: 2020-2025

3.2.2 Global Ocular Drug Delivery Sales by Region: 2026-2031

3.3 Global Ocular Drug Delivery Revenue by Region: 2020-2031

3.3.1 Global Ocular Drug Delivery Revenue by Region: 2020-2025

3.3.2 Global Ocular Drug Delivery Revenue by Region: 2026-2031

3.4 North America Ocular Drug Delivery Market Facts & Figures by Country

3.4.1 North America Ocular Drug Delivery Market Size by Country: 2020 VS 2024 VS 2031

3.4.2 North America Ocular Drug Delivery Sales by Country (2020-2031)

3.4.3 North America Ocular Drug Delivery Revenue by Country (2020-2031)

3.4.4 U.S.

3.4.5 Canada

3.5 Europe Ocular Drug Delivery Market Facts & Figures by Country

3.5.1 Europe Ocular Drug Delivery Market Size by Country: 2020 VS 2024 VS 2031

3.5.2 Europe Ocular Drug Delivery Sales by Country (2020-2031)

3.5.3 Europe Ocular Drug Delivery Revenue by Country (2020-2031)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific Ocular Drug Delivery Market Facts & Figures by Region

3.6.1 Asia Pacific Ocular Drug Delivery Market Size by Region: 2020 VS 2024 VS 2031

3.6.2 Asia Pacific Ocular Drug Delivery Sales by Region (2020-2031)

3.6.3 Asia Pacific Ocular Drug Delivery Revenue by Region (2020-2031)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 Taiwan

3.6.10 Indonesia

3.6.11 Thailand

3.6.12 Malaysia

3.6.13 Philippines

3.7 Latin America Ocular Drug Delivery Market Facts & Figures by Country

3.7.1 Latin America Ocular Drug Delivery Market Size by Country: 2020 VS 2024 VS 2031

3.7.2 Latin America Ocular Drug Delivery Sales by Country (2020-2031)

3.7.3 Latin America Ocular Drug Delivery Revenue by Country (2020-2031)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.8 Middle East and Africa Ocular Drug Delivery Market Facts & Figures by Country

3.8.1 Middle East and Africa Ocular Drug Delivery Market Size by Country: 2020 VS 2024 VS 2031

3.8.2 Middle East and Africa Ocular Drug Delivery Sales by Country (2020-2031)

3.8.3 Middle East and Africa Ocular Drug Delivery Revenue by Country (2020-2031)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 U.A.E

4 Segment by Type

4.1 Global Ocular Drug Delivery Sales by Type (2020-2031)

4.1.1 Global Ocular Drug Delivery Sales by Type (2020-2025)

4.1.2 Global Ocular Drug Delivery Sales by Type (2026-2031)

4.1.3 Global Ocular Drug Delivery Sales Market Share by Type (2020-2031)

4.2 Global Ocular Drug Delivery Revenue by Type (2020-2031)

4.2.1 Global Ocular Drug Delivery Revenue by Type (2020-2025)

4.2.2 Global Ocular Drug Delivery Revenue by Type (2026-2031)

4.2.3 Global Ocular Drug Delivery Revenue Market Share by Type (2020-2031)

4.3 Global Ocular Drug Delivery Price by Type (2020-2031)

5 Segment by Application

5.1 Global Ocular Drug Delivery Sales by Application (2020-2031)

5.1.1 Global Ocular Drug Delivery Sales by Application (2020-2025)

5.1.2 Global Ocular Drug Delivery Sales by Application (2026-2031)

5.1.3 Global Ocular Drug Delivery Sales Market Share by Application (2020-2031)

5.2 Global Ocular Drug Delivery Revenue by Application (2020-2031)

5.2.1 Global Ocular Drug Delivery Revenue by Application (2020-2025)

5.2.2 Global Ocular Drug Delivery Revenue by Application (2026-2031)

5.2.3 Global Ocular Drug Delivery Revenue Market Share by Application (2020-2031)

5.3 Global Ocular Drug Delivery Price by Application (2020-2031)

6 Key Companies Profiled

6.1 OCULAR THERAPEUTIX, INC

6.1.1 OCULAR THERAPEUTIX, INC Company Information

6.1.2 OCULAR THERAPEUTIX, INC Description and Business Overview

6.1.3 OCULAR THERAPEUTIX, INC Ocular Drug Delivery Sales, Revenue and Gross Margin (2020-2025)

6.1.4 OCULAR THERAPEUTIX, INC Ocular Drug Delivery Product Portfolio

6.1.5 OCULAR THERAPEUTIX, INC Recent Developments/Updates

6.2 Alimera Sciences

6.2.1 Alimera Sciences Company Information

6.2.2 Alimera Sciences Description and Business Overview

6.2.3 Alimera Sciences Ocular Drug Delivery Sales, Revenue and Gross Margin (2020-2025)

6.2.4 Alimera Sciences Ocular Drug Delivery Product Portfolio

6.2.5 Alimera Sciences Recent Developments/Updates

6.3 Allergan, Plc

6.3.1 Allergan, Plc Company Information

6.3.2 Allergan, Plc Description and Business Overview

6.3.3 Allergan, Plc Ocular Drug Delivery Sales, Revenue and Gross Margin (2020-2025)

6.3.4 Allergan, Plc Ocular Drug Delivery Product Portfolio

6.3.5 Allergan, Plc Recent Developments/Updates

6.4 EyeGate Pharma

6.4.1 EyeGate Pharma Company Information

6.4.2 EyeGate Pharma Description and Business Overview

6.4.3 EyeGate Pharma Ocular Drug Delivery Sales, Revenue and Gross Margin (2020-2025)

6.4.4 EyeGate Pharma Ocular Drug Delivery Product Portfolio

6.4.5 EyeGate Pharma Recent Developments/Updates

6.5 Valeant Pharmaceuticals International, Inc

6.5.1 Valeant Pharmaceuticals International, Inc Company Information

6.5.2 Valeant Pharmaceuticals International, Inc Description and Business Overview

6.5.3 Valeant Pharmaceuticals International, Inc Ocular Drug Delivery Sales, Revenue and Gross Margin (2020-2025)

6.5.4 Valeant Pharmaceuticals International, Inc Ocular Drug Delivery Product Portfolio

6.5.5 Valeant Pharmaceuticals International, Inc Recent Developments/Updates

6.6 Envisia Therapeutics

6.6.1 Envisia Therapeutics Company Information

6.6.2 Envisia Therapeutics Description and Business Overview

6.6.3 Envisia Therapeutics Ocular Drug Delivery Sales, Revenue and Gross Margin (2020-2025)

6.6.4 Envisia Therapeutics Ocular Drug Delivery Product Portfolio

6.6.5 Envisia Therapeutics Recent Developments/Updates

6.7 Clearside Biomedical

6.7.1 Clearside Biomedical Company Information

6.7.2 Clearside Biomedical Description and Business Overview

6.7.3 Clearside Biomedical Ocular Drug Delivery Sales, Revenue and Gross Margin (2020-2025)

6.7.4 Clearside Biomedical Ocular Drug Delivery Product Portfolio

6.7.5 Clearside Biomedical Recent Developments/Updates

6.8 Graybug Vision Inc

6.8.1 Graybug Vision Inc Company Information

6.8.2 Graybug Vision Inc Description and Business Overview

6.8.3 Graybug Vision Inc Ocular Drug Delivery Sales, Revenue and Gross Margin (2020-2025)

6.8.4 Graybug Vision Inc Ocular Drug Delivery Product Portfolio

6.8.5 Graybug Vision Inc Recent Developments/Updates

6.9 Taiwan Liposome Company

6.9.1 Taiwan Liposome Company Company Information

6.9.2 Taiwan Liposome Company Description and Business Overview

6.9.3 Taiwan Liposome Company Ocular Drug Delivery Sales, Revenue and Gross Margin (2020-2025)

6.9.4 Taiwan Liposome Company Ocular Drug Delivery Product Portfolio

6.9.5 Taiwan Liposome Company Recent Developments/Updates

6.10 Santen Pharmaceutical

6.10.1 Santen Pharmaceutical Company Information

6.10.2 Santen Pharmaceutical Description and Business Overview

6.10.3 Santen Pharmaceutical Ocular Drug Delivery Sales, Revenue and Gross Margin (2020-2025)

6.10.4 Santen Pharmaceutical Ocular Drug Delivery Product Portfolio

6.10.5 Santen Pharmaceutical Recent Developments/Updates

7 Industry Chain and Sales Channels Analysis

7.1 Ocular Drug Delivery Industry Chain Analysis

7.2 Ocular Drug Delivery Raw Material Supply Analysis

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 Ocular Drug Delivery Production Mode & Process Analysis

7.4 Ocular Drug Delivery Sales and Marketing

7.4.1 Ocular Drug Delivery Sales Channels

7.4.2 Ocular Drug Delivery Distributors

7.5 Ocular Drug Delivery Customer Analysis

8 Ocular Drug Delivery Market Dynamics

8.1 Ocular Drug Delivery Industry Trends

8.2 Ocular Drug Delivery Market Drivers

8.3 Ocular Drug Delivery Market Challenges

8.4 Ocular Drug Delivery Market Restraints

9 Research Findings and Conclusion

10 Methodology and Data Source

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

FEATURED COMPANIES

Ocular Therapeutix Inc

Alimera Sciences

Allergan plc

Eyegate Pharma

Valeant Pharmaceuticals International Inc

Envisia Therapeutics

Clearside Biomedical

Graybug Vision Inc

Taiwan Liposome Company

Santen Pharmaceutical

List of Tables

Table 1. Global Ocular Drug Delivery Market Value Comparison by Type (2024 VS 2031) & (US$ Million)

Table 2. Global Ocular Drug Delivery Market Value by Application (2024 VS 2031) & (US$ Million)

Table 3. Global Ocular Drug Delivery Market Competitive Situation by Manufacturers in 2024

Table 4. Global Ocular Drug Delivery Sales (K Doses) of Key Manufacturers (2020-2025)

Table 5. Global Ocular Drug Delivery Sales Market Share by Manufacturers (2020-2025)

Table 6. Global Ocular Drug Delivery Revenue (US$ Million) by Manufacturers (2020-2025)

Table 7. Global Ocular Drug Delivery Revenue Share by Manufacturers (2020-2025)

Table 8. Global Market Ocular Drug Delivery Average Price (USD/Dose) of Key Manufacturers (2020-2025)

Table 9. Global Key Players of Ocular Drug Delivery, Industry Ranking, 2022 VS 2023 VS 2024

Table 10. Global Key Manufacturers of Ocular Drug Delivery, Manufacturing Sites & Headquarters

Table 11. Global Key Manufacturers of Ocular Drug Delivery, Product Type & Application

Table 12. Global Key Manufacturers of Ocular Drug Delivery, Date of Enter into This Industry

Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Ocular Drug Delivery by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Ocular Drug Delivery as of 2024)

Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 16. Global Ocular Drug Delivery Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 17. Global Ocular Drug Delivery Sales by Region (2020-2025) & (K Doses)

Table 18. Global Ocular Drug Delivery Sales Market Share by Region (2020-2025)

Table 19. Global Ocular Drug Delivery Sales by Region (2026-2031) & (K Doses)

Table 20. Global Ocular Drug Delivery Sales Market Share by Region (2026-2031)

Table 21. Global Ocular Drug Delivery Revenue by Region (2020-2025) & (US$ Million)

Table 22. Global Ocular Drug Delivery Revenue Market Share by Region (2020-2025)

Table 23. Global Ocular Drug Delivery Revenue by Region (2026-2031) & (US$ Million)

Table 24. Global Ocular Drug Delivery Revenue Market Share by Region (2026-2031)

Table 25. North America Ocular Drug Delivery Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 26. North America Ocular Drug Delivery Sales by Country (2020-2025) & (K Doses)

Table 27. North America Ocular Drug Delivery Sales by Country (2026-2031) & (K Doses)

Table 28. North America Ocular Drug Delivery Revenue by Country (2020-2025) & (US$ Million)

Table 29. North America Ocular Drug Delivery Revenue by Country (2026-2031) & (US$ Million)

Table 30. Europe Ocular Drug Delivery Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 31. Europe Ocular Drug Delivery Sales by Country (2020-2025) & (K Doses)

Table 32. Europe Ocular Drug Delivery Sales by Country (2026-2031) & (K Doses)

Table 33. Europe Ocular Drug Delivery Revenue by Country (2020-2025) & (US$ Million)

Table 34. Europe Ocular Drug Delivery Revenue by Country (2026-2031) & (US$ Million)

Table 35. Asia Pacific Ocular Drug Delivery Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)

Table 36. Asia Pacific Ocular Drug Delivery Sales by Region (2020-2025) & (K Doses)

Table 37. Asia Pacific Ocular Drug Delivery Sales by Region (2026-2031) & (K Doses)

Table 38. Asia Pacific Ocular Drug Delivery Revenue by Region (2020-2025) & (US$ Million)

Table 39. Asia Pacific Ocular Drug Delivery Revenue by Region (2026-2031) & (US$ Million)

Table 40. Latin America Ocular Drug Delivery Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 41. Latin America Ocular Drug Delivery Sales by Country (2020-2025) & (K Doses)

Table 42. Latin America Ocular Drug Delivery Sales by Country (2026-2031) & (K Doses)

Table 43. Latin America Ocular Drug Delivery Revenue by Country (2020-2025) & (US$ Million)

Table 44. Latin America Ocular Drug Delivery Revenue by Country (2026-2031) & (US$ Million)

Table 45. Middle East and Africa Ocular Drug Delivery Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 46. Middle East and Africa Ocular Drug Delivery Sales by Country (2020-2025) & (K Doses)

Table 47. Middle East and Africa Ocular Drug Delivery Sales by Country (2026-2031) & (K Doses)

Table 48. Middle East and Africa Ocular Drug Delivery Revenue by Country (2020-2025) & (US$ Million)

Table 49. Middle East and Africa Ocular Drug Delivery Revenue by Country (2026-2031) & (US$ Million)

Table 50. Global Ocular Drug Delivery Sales (K Doses) by Type (2020-2025)

Table 51. Global Ocular Drug Delivery Sales (K Doses) by Type (2026-2031)

Table 52. Global Ocular Drug Delivery Sales Market Share by Type (2020-2025)

Table 53. Global Ocular Drug Delivery Sales Market Share by Type (2026-2031)

Table 54. Global Ocular Drug Delivery Revenue (US$ Million) by Type (2020-2025)

Table 55. Global Ocular Drug Delivery Revenue (US$ Million) by Type (2026-2031)

Table 56. Global Ocular Drug Delivery Revenue Market Share by Type (2020-2025)

Table 57. Global Ocular Drug Delivery Revenue Market Share by Type (2026-2031)

Table 58. Global Ocular Drug Delivery Price (USD/Dose) by Type (2020-2025)

Table 59. Global Ocular Drug Delivery Price (USD/Dose) by Type (2026-2031)

Table 60. Global Ocular Drug Delivery Sales (K Doses) by Application (2020-2025)

Table 61. Global Ocular Drug Delivery Sales (K Doses) by Application (2026-2031)

Table 62. Global Ocular Drug Delivery Sales Market Share by Application (2020-2025)

Table 63. Global Ocular Drug Delivery Sales Market Share by Application (2026-2031)

Table 64. Global Ocular Drug Delivery Revenue (US$ Million) by Application (2020-2025)

Table 65. Global Ocular Drug Delivery Revenue (US$ Million) by Application (2026-2031)

Table 66. Global Ocular Drug Delivery Revenue Market Share by Application (2020-2025)

Table 67. Global Ocular Drug Delivery Revenue Market Share by Application (2026-2031)

Table 68. Global Ocular Drug Delivery Price (USD/Dose) by Application (2020-2025)

Table 69. Global Ocular Drug Delivery Price (USD/Dose) by Application (2026-2031)

Table 70. OCULAR THERAPEUTIX, INC Company Information

Table 71. OCULAR THERAPEUTIX, INC Description and Business Overview

Table 72. OCULAR THERAPEUTIX, INC Ocular Drug Delivery Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2020-2025)

Table 73. OCULAR THERAPEUTIX, INC Ocular Drug Delivery Product

Table 74. OCULAR THERAPEUTIX, INC Recent Developments/Updates

Table 75. Alimera Sciences Company Information

Table 76. Alimera Sciences Description and Business Overview

Table 77. Alimera Sciences Ocular Drug Delivery Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2020-2025)

Table 78. Alimera Sciences Ocular Drug Delivery Product

Table 79. Alimera Sciences Recent Developments/Updates

Table 80. Allergan, Plc Company Information

Table 81. Allergan, Plc Description and Business Overview

Table 82. Allergan, Plc Ocular Drug Delivery Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2020-2025)

Table 83. Allergan, Plc Ocular Drug Delivery Product

Table 84. Allergan, Plc Recent Developments/Updates

Table 85. EyeGate Pharma Company Information

Table 86. EyeGate Pharma Description and Business Overview

Table 87. EyeGate Pharma Ocular Drug Delivery Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2020-2025)

Table 88. EyeGate Pharma Ocular Drug Delivery Product

Table 89. EyeGate Pharma Recent Developments/Updates

Table 90. Valeant Pharmaceuticals International, Inc Company Information

Table 91. Valeant Pharmaceuticals International, Inc Description and Business Overview

Table 92. Valeant Pharmaceuticals International, Inc Ocular Drug Delivery Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2020-2025)

Table 93. Valeant Pharmaceuticals International, Inc Ocular Drug Delivery Product

Table 94. Valeant Pharmaceuticals International, Inc Recent Developments/Updates

Table 95. Envisia Therapeutics Company Information

Table 96. Envisia Therapeutics Description and Business Overview

Table 97. Envisia Therapeutics Ocular Drug Delivery Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2020-2025)

Table 98. Envisia Therapeutics Ocular Drug Delivery Product

Table 99. Envisia Therapeutics Recent Developments/Updates

Table 100. Clearside Biomedical Company Information

Table 101. Clearside Biomedical Description and Business Overview

Table 102. Clearside Biomedical Ocular Drug Delivery Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2020-2025)

Table 103. Clearside Biomedical Ocular Drug Delivery Product

Table 104. Clearside Biomedical Recent Developments/Updates

Table 105. Graybug Vision Inc Company Information

Table 106. Graybug Vision Inc Description and Business Overview

Table 107. Graybug Vision Inc Ocular Drug Delivery Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2020-2025)

Table 108. Graybug Vision Inc Ocular Drug Delivery Product

Table 109. Graybug Vision Inc Recent Developments/Updates

Table 110. Taiwan Liposome Company Company Information

Table 111. Taiwan Liposome Company Description and Business Overview

Table 112. Taiwan Liposome Company Ocular Drug Delivery Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2020-2025)

Table 113. Taiwan Liposome Company Ocular Drug Delivery Product

Table 114. Taiwan Liposome Company Recent Developments/Updates

Table 115. Santen Pharmaceutical Company Information

Table 116. Santen Pharmaceutical Description and Business Overview

Table 117. Santen Pharmaceutical Ocular Drug Delivery Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2020-2025)

Table 118. Santen Pharmaceutical Ocular Drug Delivery Product

Table 119. Santen Pharmaceutical Recent Developments/Updates

Table 120. Key Raw Materials Lists

Table 121. Raw Materials Key Suppliers Lists

Table 122. Ocular Drug Delivery Distributors List

Table 123. Ocular Drug Delivery Customers List

Table 124. Ocular Drug Delivery Market Trends

Table 125. Ocular Drug Delivery Market Drivers

Table 126. Ocular Drug Delivery Market Challenges

Table 127. Ocular Drug Delivery Market Restraints

Table 128. Research Programs/Design for This Report

Table 129. Key Data Information from Secondary Sources

Table 130. Key Data Information from Primary Sources

Table 131. Authors List of This Report

List of Figures

Figure 1. Product Picture of Ocular Drug Delivery

Figure 2. Global Ocular Drug Delivery Market Value Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Ocular Drug Delivery Market Share by Type: 2024 & 2031

Figure 4. Ocular Insert Product Picture

Figure 5. Iontophoresis Product Picture

Figure 6. Intraocular Implants Product Picture

Figure 7. In Situ Gel & Punctal Plugs Product Picture

Figure 8. Others Product Picture

Figure 9. Global Ocular Drug Delivery Market Value by Application (2020-2031) & (US$ Million)

Figure 10. Global Ocular Drug Delivery Market Share by Application: 2024 & 2031

Figure 11. Hospitals

Figure 12. Ambulatory Surgical Centers

Figure 13. Ophthalmic Clinics

Figure 14. Homecare Settings

Figure 15. Global Ocular Drug Delivery Revenue, (US$ Million), 2020 VS 2024 VS 2031

Figure 16. Global Ocular Drug Delivery Market Size (2020-2031) & (US$ Million)

Figure 17. Global Ocular Drug Delivery Sales (2020-2031) & (K Doses)

Figure 18. Global Ocular Drug Delivery Average Price (USD/Dose) & (2020-2031)

Figure 19. Ocular Drug Delivery Report Years Considered

Figure 20. Ocular Drug Delivery Sales Share by Manufacturers in 2024

Figure 21. Global Ocular Drug Delivery Revenue Share by Manufacturers in 2024

Figure 22. Global 5 and 10 Largest Ocular Drug Delivery Players: Market Share by Revenue in Ocular Drug Delivery in 2024

Figure 23. Ocular Drug Delivery Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024

Figure 24. Global Ocular Drug Delivery Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Figure 25. North America Ocular Drug Delivery Sales Market Share by Country (2020-2031)

Figure 26. North America Ocular Drug Delivery Revenue Market Share by Country (2020-2031)

Figure 27. U.S. Ocular Drug Delivery Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 28. Canada Ocular Drug Delivery Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 29. Europe Ocular Drug Delivery Sales Market Share by Country (2020-2031)

Figure 30. Europe Ocular Drug Delivery Revenue Market Share by Country (2020-2031)

Figure 31. Germany Ocular Drug Delivery Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 32. France Ocular Drug Delivery Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 33. U.K. Ocular Drug Delivery Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 34. Italy Ocular Drug Delivery Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 35. Russia Ocular Drug Delivery Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 36. Asia Pacific Ocular Drug Delivery Sales Market Share by Region (2020-2031)

Figure 37. Asia Pacific Ocular Drug Delivery Revenue Market Share by Region (2020-2031)

Figure 38. China Ocular Drug Delivery Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 39. Japan Ocular Drug Delivery Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 40. South Korea Ocular Drug Delivery Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 41. India Ocular Drug Delivery Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 42. Australia Ocular Drug Delivery Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 43. Taiwan Ocular Drug Delivery Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 44. Indonesia Ocular Drug Delivery Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 45. Thailand Ocular Drug Delivery Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 46. Malaysia Ocular Drug Delivery Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 47. Philippines Ocular Drug Delivery Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 48. Latin America Ocular Drug Delivery Sales Market Share by Country (2020-2031)

Figure 49. Latin America Ocular Drug Delivery Revenue Market Share by Country (2020-2031)

Figure 50. Mexico Ocular Drug Delivery Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 51. Brazil Ocular Drug Delivery Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 52. Argentina Ocular Drug Delivery Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 53. Middle East and Africa Ocular Drug Delivery Sales Market Share by Country (2020-2031)

Figure 54. Middle East and Africa Ocular Drug Delivery Revenue Market Share by Country (2020-2031)

Figure 55. Turkey Ocular Drug Delivery Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 56. Saudi Arabia Ocular Drug Delivery Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 57. U.A.E Ocular Drug Delivery Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 58. Global Sales Market Share of Ocular Drug Delivery by Type (2020-2031)

Figure 59. Global Revenue Market Share of Ocular Drug Delivery by Type (2020-2031)

Figure 60. Global Ocular Drug Delivery Price (USD/Dose) by Type (2020-2031)

Figure 61. Global Sales Market Share of Ocular Drug Delivery by Application (2020-2031)

Figure 62. Global Revenue Market Share of Ocular Drug Delivery by Application (2020-2031)

Figure 63. Global Ocular Drug Delivery Price (USD/Dose) by Application (2020-2031)

Figure 64. Ocular Drug Delivery Value Chain

Figure 65. Channels of Distribution (Direct Vs Distribution)

Figure 66. Bottom-up and Top-down Approaches for This Report

Figure 67. Data Triangulation

Figure 68. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Ophthalmic Drug Delivery Device Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Eye Drug Market Insights Forecast to 2030

Ophthalmology Therapeutics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Ophthalmic Anti Infective Drugs Market Research Report 2025

Global Retinal Disorder Treatment Market Research Report 2024

Global Ophthalmology AI assisted Diagnosis Software Market Research Report 2024

Global Pharma Ophthalmic Market Research Report 2025

Ophthalmic Pharmaceutical Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Sustained Release Ocular Drug Delivery Systems Market Research Report 2025

Global Still s Disease Treatment Market Research Report 2025

Ophthalmic Therapeutics Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Eye Inflammation Treatment Market Research Report 2025

Global Treatment Planning Software Market Research Report 2025

Global Pharmaceutical Filter Aid Market Research Report 2025

Global Drug Safety and Pharmacovigilance Service Market Research Report 2025

Global Pill Organizer with Timer Reminder Market Research Report 2025

Computer Vision in Pharmaceutical Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Chemical Dosing Units Market Research Report 2025

Global Pharmaceutical Validation Services Market Research Report 2025

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

[email protected]

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions

	
		OSZAR »